Panacea: Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

Panacea Life Sciences Holdings, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 2.38 million compared to USD 1.63 million a year ago. Net loss was USD 8.02 million compared to USD 9.14 million a year ago. Basic loss per share from continuing operations was USD 0.48 compared to USD 0.62 a year ago. Diluted loss per share from continuing operations was USD 0.48 compared to USD 0.62 a year ago.